Nuvo Pharmaceuticals Inc NRIFF

Primary Symbol: MRVFF

Healthcare Drug Manufacturers - Specialty & Generic

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.

OTCQX:MRVFF - Post by User

Nuvo Pharmaceuticals Inc

Bullboard Posts

Post by need2stockupon Mar 11, 2013 8:01pm

220 Views

Post# 21113559

Voltaren takes commanding lead

We know my last post about Voltaren's $ 700,000,000.00 + Voltaren 2012 sales figures. Pennsaid did $ 423,000.00 for the 3 months ending September 30, 2013. If you times that by 4 you get $ 1,692,000.00 for the year. That is not exactly correct, but we are only $ 698 million behind Voltaren. Giddy yup Nuvo. Need2.

Product Sales and Gross Margin

in thousands (except gross margin percentage)

1. Pennsaid sales
2. Synera sales
3. WF10 sales
4. Total product sales
5. Cost of goods sold
6. Gross margin

7. (loss) on product sales Gross margin percentage

Three months ended September 30, September 30, 2012 2011

1. $423,000.00

2. $247,000.00

3. $342,000.00

4. $1,012,000.00

5. $1,327,000.00

6. (315,000.00)

7. (31)%